Brain Pacemaker Market is expected to reach USD 3,740.81 million by the year 2026, With Top Players Are PINS medical, Boston group, Abbott, etc.

According to the current analysis of Reports and Data, the global Brain Pacemakers market is expected to reach USD 3,740.81 million by the year 2026, in terms of value at a CAGR of 15.9%. Brain pacemaker is a neurostimulator, having an ability to send electrical impulses, through implanted electrodes, to specific targets in the brain for the treatment of neurological disorders.

Avail the inside scoop of the Sample report @ https://www.reportsanddata.com/sample-enquiry-form/1999

Companies considered and profiled in this market study
PINS medical, Boston group, Abbott, and Medtronic, Aleva neurotherapeutics, and others

Deep brain stimulation (DBS) is a neurosurgical procedure involving the placement of brain pacemakers to treat neurological disorders. Increasing healthcare expenditure investments in the market, which augment the technological advancements in brain pacemakers are estimated to shape the growth of the brain pacemaker market. These advancements include enhanced microelectrode designs, robot-assisted implantation, multi-target stimulation, integrated implantable pulse generators, individualized directed programming, and magnetic resonance imaging (MRI).

Due to the technological advancements in recent times, brain pacemakers have demonstrated lesser adverse effects and greater efficacy and symptomatic relief in patients with movement disorders as compared to conventional methods. Also, the potential benefits of deep brain stimulation therapy, such as better management of postoperative outcomes and long-term efficacy, are projected to facilitate growth of the brain pacemaker market over the forecast period.

Key findings from the report suggest

1. The single channel product type segment of global brain pacemaker market is expected to grow at a high CAGR by 2026. The significant share is due to the use & adoption of the single channel devices across different medical settings. This segment is observed to grow enormously in the study period

2. Different products are anticipated to be launched in the analysis period in the brain pacemaker market. Abbot is anticipated to improve on its its St. Jude medical infinity

3. Along with groundbreaking technology to help Parkinson's, this system uses a wireless IOS device (an Apple iPod) to control stimulation. It is a feature allows patients to receive discreet, personalized treatment in the palm of their hand.

4. The handheld programmer will enable to control how much or how little stimulation the patient needs, which is another breakthrough to enhance patient care.

5. Clinical evidence from the INTREPID study reported that patients treated with the Vercise System sustained a 48% improvement in motor function as measured by the Unified Parkinson's Disease Rating Scale (UPDRS).

6. Abbott Laboratories acquired the DBS business with its acquisition of St. Jude Medical last year; and Boston Scientific, which currently offers its DBS system in Europe, hopes to receive U.S. approval by year-end. The combined company aimed to offer potent health resources and advanced connected medical devices to gain momentum in the health care industry.

7. An estimated ten million people globally are affected by Parkinson's disease, causing symptoms such as shaking or tremors, muscle stiffness, and slowness of movement.

Click here to Get customization & check available discount for the report @ https://www.reportsanddata.com/discount-enquiry-form/1999

Market segmentation:

This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the industry trends in each of the sub-segments from 2016 to 2026. For the purpose of this study, Reports and Data have segmented the brain pacemaker market into product types, application types, sales channel, end user type and region.

Based on the product: (Revenue, USD Million; 2016-2026):
Single Channel
Dual Channel

Based on Applications (Revenue, USD Million; 2016-2026):

Parkinson's Disease
Epilepsy
Dystonia
Alzheimer's
Essential Tremor
Obsessive-Compulsive Disorder

Based on the end-user: (Revenue, USD Million; 2016-2026)

Hospitals
Ambulatory Surgical Centers & Clinics
Others

Based on the Sales channel (Revenue, USD Million; 2016-2026)

Channel sales
Direct sales

Based on Region (Revenue, USD Million; 2016-2026)

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Find the extensive Report Description, TOC and Table of Figure @ https://www.reportsanddata.com/report-detail/brain-pacemaker-market

Key selling points of this research study

1. The study gives an in-depth evaluation of the evolving competitive scenario that gives the reader/client a competitive edge.

2. It offers a holistic view of all critical aspects boosting or limiting the growth of the sector

3. The market intelligence report derives an eight-year forecast, including historical, contemporary, and potential market prospects, projecting the estimated progress of the market.

4. It aids informed decision-making by offering an exhaustive database of the pivotal market segments and sub-segments

Contact Us:

John Watson
Head of Business Development
Reports And Data
40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Reports and Data | Web: www.reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.